We work with partners in academia, health-care, industry and patient groups to help realize the potential of genomic medicine in neurological disorders. Our primary focus is amyotrophic lateral sclerosis, a devastating neurodegenerative disease that causes progressive paralysis, muscle wasting and death (lifetime risk ~ 1/350).

Our work integrates petabytes of data from global DNA sequencing efforts with experimental readouts from analyses of patient tissue and disease models (transcriptomics, epigenomics…).

We employ a wide variety of computational techniques, including our own adaptations of traditional bioinformatic methods and recent advances in AI / machine learning.

For publications see https://pubmed.ncbi.nlm.nih.gov/?term=Kevin+Kenna.